Smartleaf Asset Management LLC raised its stake in shares of Core Laboratories Inc. (NYSE:CLB – Free Report) by 173.8% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 2,037 shares of the oil and gas company’s stock after acquiring an additional 1,293 shares during the period. Smartleaf Asset Management LLC’s holdings in Core Laboratories were worth $35,000 as of its most recent SEC filing.
A number of other hedge funds have also recently made changes to their positions in the stock. Nisa Investment Advisors LLC boosted its position in Core Laboratories by 2,688.5% in the 4th quarter. Nisa Investment Advisors LLC now owns 2,426 shares of the oil and gas company’s stock valued at $42,000 after buying an additional 2,339 shares during the period. Isthmus Partners LLC increased its stake in Core Laboratories by 18.8% in the third quarter. Isthmus Partners LLC now owns 10,620 shares of the oil and gas company’s stock valued at $197,000 after purchasing an additional 1,682 shares during the period. Quantbot Technologies LP purchased a new stake in shares of Core Laboratories in the third quarter valued at about $211,000. Integrated Investment Consultants LLC boosted its holdings in shares of Core Laboratories by 19.9% in the third quarter. Integrated Investment Consultants LLC now owns 16,290 shares of the oil and gas company’s stock valued at $302,000 after acquiring an additional 2,709 shares in the last quarter. Finally, Connable Office Inc. boosted its holdings in Core Laboratories by 18.1% during the third quarter. Connable Office Inc. now owns 16,793 shares of the oil and gas company’s stock worth $311,000 after buying an additional 2,569 shares in the last quarter. Hedge funds and other institutional investors own 97.81% of the company’s stock.
Core Laboratories Stock Performance
NYSE:CLB opened at $15.10 on Thursday. The firm has a 50 day simple moving average of $17.24 and a 200-day simple moving average of $18.37. The company has a debt-to-equity ratio of 0.49, a current ratio of 2.32 and a quick ratio of 1.71. The firm has a market cap of $706.90 million, a PE ratio of 22.87, a P/E/G ratio of 0.99 and a beta of 2.38. Core Laboratories Inc. has a 1-year low of $12.95 and a 1-year high of $25.13.
Core Laboratories Dividend Announcement
The company also recently announced a quarterly dividend, which was paid on Monday, March 3rd. Stockholders of record on Monday, February 10th were paid a $0.01 dividend. The ex-dividend date was Monday, February 10th. This represents a $0.04 annualized dividend and a dividend yield of 0.26%. Core Laboratories’s dividend payout ratio (DPR) is presently 6.06%.
Analyst Upgrades and Downgrades
Separately, Citigroup raised shares of Core Laboratories from a “sell” rating to a “neutral” rating and boosted their price objective for the stock from $15.00 to $16.00 in a report on Wednesday. One analyst has rated the stock with a sell rating and four have issued a hold rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus target price of $17.50.
Check Out Our Latest Stock Report on CLB
Core Laboratories Company Profile
Core Laboratories Inc provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and gas from its clients' reservoirs.
Further Reading
- Five stocks we like better than Core Laboratories
- What Are Dividend Contenders? Investing in Dividend Contenders
- Ramaco Resources Pins Hopes on Coal’s Untapped Potential
- Basic Materials Stocks Investing
- NVIDIA’s Soaring Energy Needs Make These 3 Nuclear Stocks a Buy
- What is a Secondary Public Offering? What Investors Need to Know
- Why Energy Transfer Belongs on Your Watchlist
Want to see what other hedge funds are holding CLB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Core Laboratories Inc. (NYSE:CLB – Free Report).
Receive News & Ratings for Core Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Core Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.